Showing results (11-20 of 24) with videos related to
Sort By:
Pageof 3
Journal of Dermatological Science|September 25, 2012
Histone deacetylases inhibitor Trichostatin A ameliorates DNFB-induced allergic contact dermatitis and reduces epidermal Langerhans cells in miceYu-Ling Shi, Jun Gu, Jang-June Park, et al.ACS Omega|July 29, 2024
Molecular Dynamics Simulation on the Suppression Mechanism of Phosphorylation to Ser222 by Allosteric Inhibitors Targeting MEK1/2 KinaseSathish K Mudedla, Hayoung Lee, Jeom Ji Kim, et al.Proceedings of the National Academy of Sciences of the United States of America|February 11, 2003
Defective presentation of the CD1d1-restricted natural Va14Ja18 NKT lymphocyte antigen caused by beta-D-glucosylceramide synthase deficiencyAleksandar K Stanic, A Dharshan De Silva, Jang-June Park, et al.The Journal of Clinical Investigation|November 15, 2011
Herpesvirus entry mediator regulates hypoxia-inducible factor-1α and erythropoiesis in miceYukimi Sakoda, Sudarshan Anand, Yuming Zhao, et al.Scientific Reports|April 2, 2020
Publisher Correction: Circulating serum HBsAg level is a biomarker for HBV-specific T and B cell responses in chronic hepatitis B patientsJin Hyang Kim, Alip Ghosh, Natarajan Ayithan, et al.Scientific Reports|February 6, 2020
Circulating serum HBsAg level is a biomarker for HBV-specific T and B cell responses in chronic hepatitis B patientsJin Hyang Kim, Alip Ghosh, Natarajan Ayithan, et al.Journal of Virology|March 10, 2017
Modulation of Hepatitis C Virus-Specific CD8 Effector T-Cell Function with Antiviral Effect in Infectious Hepatitis C Virus Coculture ModelKeisuke Ojiro, Xiaowang Qu, Hyosun Cho, et al.Blood|May 18, 2010
B7-H1/CD80 interaction is required for the induction and maintenance of peripheral T-cell toleranceJang-June Park, Ryusuke Omiya, Yumiko Matsumura, et al.Journal of Immunology (Baltimore, Md. : 1950)|August 7, 2003
Immunoregulatory role of CD1d in the hydrocarbon oil-induced model of lupus nephritisJun-Qi Yang, Avneesh K Singh, Michael T Wilson, et al.Cancer Immunology, Immunotherapy : CII|January 3, 2025
Therapeutic potential of anti-ErbB3 chimeric antigen receptor natural killer cells against breast cancerJuheon Lee, Jinhoo Song, Wonbeak Yoo, et al.Pageof 3